DE69426879D1 - Plasma-artige lösung - Google Patents

Plasma-artige lösung

Info

Publication number
DE69426879D1
DE69426879D1 DE69426879T DE69426879T DE69426879D1 DE 69426879 D1 DE69426879 D1 DE 69426879D1 DE 69426879 T DE69426879 T DE 69426879T DE 69426879 T DE69426879 T DE 69426879T DE 69426879 D1 DE69426879 D1 DE 69426879D1
Authority
DE
Germany
Prior art keywords
solution
plasma
disclosed
dextran
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69426879T
Other languages
English (en)
Other versions
DE69426879T2 (de
Inventor
E Segall
Hal Sternberg
D Waitz
M Segall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotime Inc
Original Assignee
Biotime Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26752331&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69426879(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/071,533 external-priority patent/US5407428A/en
Application filed by Biotime Inc filed Critical Biotime Inc
Application granted granted Critical
Publication of DE69426879D1 publication Critical patent/DE69426879D1/de
Publication of DE69426879T2 publication Critical patent/DE69426879T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0221—Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0278—Physical preservation processes
    • A01N1/0284—Temperature processes, i.e. using a designated change in temperature over time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
DE69426879T 1993-06-04 1994-06-03 Plasma-artige lösung Expired - Lifetime DE69426879T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/071,533 US5407428A (en) 1993-06-04 1993-06-04 Solutions for use as plasma expanders and substitutes
US13352793A 1993-10-07 1993-10-07
PCT/US1994/006279 WO1994028950A1 (en) 1993-06-04 1994-06-03 Plasma-like solution

Publications (2)

Publication Number Publication Date
DE69426879D1 true DE69426879D1 (de) 2001-04-19
DE69426879T2 DE69426879T2 (de) 2001-10-18

Family

ID=26752331

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69426879T Expired - Lifetime DE69426879T2 (de) 1993-06-04 1994-06-03 Plasma-artige lösung

Country Status (17)

Country Link
US (14) US5702880A (de)
EP (1) EP0701455B1 (de)
JP (1) JP3715312B2 (de)
KR (1) KR100267604B1 (de)
CN (1) CN1102851C (de)
AT (1) ATE199626T1 (de)
AU (1) AU681675B2 (de)
BR (1) BR9406742A (de)
CA (1) CA2164321C (de)
DE (1) DE69426879T2 (de)
DK (1) DK0701455T3 (de)
ES (1) ES2157260T3 (de)
GR (1) GR3036013T3 (de)
HK (1) HK1010698A1 (de)
PT (1) PT701455E (de)
RU (1) RU2142282C1 (de)
WO (1) WO1994028950A1 (de)

Families Citing this family (133)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3715312B2 (ja) * 1993-06-04 2005-11-09 バイオタイム インク 血漿様溶液
US6627393B2 (en) * 1993-06-04 2003-09-30 Biotime, Inc. Solutions for use as plasma expanders and substitutes
US6680305B1 (en) 1993-06-04 2004-01-20 Biotime, Inc. Physiologically acceptable aqueous solutions and methods for their use
US6300322B1 (en) * 1993-06-04 2001-10-09 Biotime, Inc. Plasma-like solution
US5945272A (en) * 1993-06-04 1999-08-31 Biotime, Incorporated Plasma expanders and blood substitutes
US6218099B1 (en) * 1994-06-03 2001-04-17 Biotime, Inc. Methods and compositions for use in perfusion applications
US6040132A (en) * 1996-06-14 2000-03-21 Biostore New Zealand, Ltd. Methods for the lyophilization of living biological materials
US6060233A (en) * 1996-06-14 2000-05-09 Biostore New Zealand, Ltd Methods for the lyophilization of platelets, platelet membranes or erythrocytes
US5827640A (en) * 1996-06-14 1998-10-27 Biostore New Zealand Limited Methods for the preservation of cells and tissues using trimethylamine oxide or betaine with raffinose or trehalose
US6387069B1 (en) * 1996-09-23 2002-05-14 Dsu Medical Corporation Blood set priming method and apparatus
US7166084B2 (en) * 1996-09-23 2007-01-23 Dsu Medical Corporation Blood set priming method and apparatus
US5804551A (en) * 1996-11-12 1998-09-08 Baxter International Inc. Pretraumatic use of hemoglobin
US5814601A (en) * 1997-02-28 1998-09-29 The Regents Of The University Of California Methods and compositions for optimization of oxygen transport by cell-free systems
US6054427A (en) * 1997-02-28 2000-04-25 The Regents Of The University Of California Methods and compositions for optimization of oxygen transport by cell-free systems
AU6865298A (en) * 1997-03-17 1998-10-12 Boris Rubinsky The use of cryoprotective agent compounds during cryosurgery
US5834178C1 (en) * 1997-07-09 2002-04-23 Univ Wayne State Flush-storage solution for donor organs
US8409846B2 (en) 1997-09-23 2013-04-02 The United States Of America As Represented By The Department Of Veteran Affairs Compositions, methods and devices for maintaining an organ
US6117166A (en) * 1997-10-27 2000-09-12 Winston; Thomas R. Apparatus and methods for grafting blood vessel tissue
SK6282000A3 (en) * 1997-10-31 2001-02-12 Biotime Inc Physiologically acceptable aqueous solutions and methods for their use
CN1068778C (zh) * 1998-05-15 2001-07-25 赵超英 救治用的药物组合物及其制备方法
US6706309B1 (en) 1998-11-25 2004-03-16 William F. Aftoora Liquefied water soluble acidity-reducing formulation for food and beverage products
EP1133244A4 (de) * 1998-11-25 2002-04-17 William F Aftoora Fluessige, wasserloesliche, aziditaetsreduzierende formulierung fuer lebensmittel und getraenke
US6589223B1 (en) 1999-02-03 2003-07-08 Biotime, Inc. Method and compositions for use in perfusion applications
US6755811B1 (en) * 1999-08-25 2004-06-29 Corazon Technologies, Inc. Methods and devices for reducing the mineral content of a region of non-intimal vascular tissue
US6846842B2 (en) 1999-10-07 2005-01-25 Beth Israel Deconess Medical Center, Inc. Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion
US6759230B1 (en) * 1999-10-26 2004-07-06 The Board Of Regents, The University Of Texas Microbe, microbial exopolysaccharide, and uses thereof
US6492103B1 (en) * 2000-01-31 2002-12-10 Organ Recovery Systems, Inc. System for organ and tissue preservation and hypothermic blood substitution
EP1586329A1 (de) * 2000-02-08 2005-10-19 Allergan, Inc. Pharmazeutische Zusammensetzungen mit botulinum Toxin
US20030118598A1 (en) * 2000-02-08 2003-06-26 Allergan, Inc. Clostridial toxin pharmaceutical compositions
US8632785B2 (en) * 2000-02-08 2014-01-21 Allergan, Inc. Clostridial toxin pharmaceutical composition containing a gelatin fragment
US7780967B2 (en) 2000-02-08 2010-08-24 Allergan, Inc. Reduced toxicity Clostridial toxin pharmaceutical compositions
US20060269575A1 (en) * 2000-02-08 2006-11-30 Allergan, Inc. Botulinum toxin pharmaceutical compositions formulated with recombinant albumin
AU2001255339A1 (en) * 2000-04-14 2001-10-30 Biotime, Inc. Systems, kits, and methods of administering synthetic plasma
CA2417331C (en) * 2000-07-28 2011-03-22 Christopher J. Murphy Transplant media comprising bnp-1
AU2002214443B2 (en) * 2000-11-03 2005-12-15 Vitrolife Ab Evaluation and preservation solution
US6746836B1 (en) 2000-12-08 2004-06-08 Abe Widra Alpha-keratose as a blood plasma expander and use thereof
US6806069B2 (en) 2001-01-09 2004-10-19 Pharmachem Laboratories, Inc. Ubiquinone composition and methods related thereto
US6864231B2 (en) * 2001-01-09 2005-03-08 Pharmachem Laboratories, Inc. Glycoprotein matrix compositions and methods related thereto
AU2002254525B2 (en) * 2001-04-04 2004-12-23 Critical Therapeutics, Inc. Method for preventing acute renal failure
US20050053912A1 (en) * 2001-06-11 2005-03-10 Roth Mark B. Methods for inducing reversible stasis
US20070213793A1 (en) * 2001-08-06 2007-09-13 Radiant Medical, Inc. Use of endovascular hypothermia in organ and/or tissue transplantations
US20070160645A1 (en) * 2001-10-25 2007-07-12 Jakob Vinten-Johansen PostConditioning System And Method For The Reduction Of Ischemic-Reperfusion Injury In The Heart And Other Organs
EP1438085B1 (de) 2001-10-25 2008-10-15 Emory University Katheter für modifizierte Perfusion
US20030153491A1 (en) * 2002-01-11 2003-08-14 Winslow Robert M. Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
US20050164915A1 (en) * 2002-04-01 2005-07-28 Sangart, Inc. Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
CA2481753A1 (en) * 2002-04-17 2003-10-30 Critical Therapeutics, Inc. Method for treating ileus with an alpha -ketoalkanoic acid or - ester or - amide
JP3912206B2 (ja) * 2002-07-05 2007-05-09 株式会社日立製作所 筒内直接燃料噴射装置用燃料ポンプ
US20070029259A1 (en) * 2003-02-04 2007-02-08 Hirotaka Kakita Method of reducing impurity content in aqueous salt solution
CN1777416B (zh) * 2003-05-01 2012-11-07 伊诺基因卡尔生物技术私人有限公司 含有乳酸根的药物组合物及其用途
ATE377609T1 (de) * 2004-03-01 2007-11-15 Braun Melsungen Ag Hydroxyethylstärke
GB0407583D0 (en) * 2004-04-05 2004-05-05 Arbab Tarig S M Diagnostic testing and related matters
US7439012B2 (en) * 2004-08-17 2008-10-21 Wake Forest University Health Sciences Ambient stored blood plasma expanders containing keratose
US8465970B2 (en) 2004-10-07 2013-06-18 Transmedics, Inc. Systems and methods for ex-vivo organ care
US8304181B2 (en) 2004-10-07 2012-11-06 Transmedics, Inc. Method for ex-vivo organ care and for using lactate as an indication of donor organ status
US9301519B2 (en) 2004-10-07 2016-04-05 Transmedics, Inc. Systems and methods for ex-vivo organ care
EP1827298A4 (de) * 2004-12-22 2011-09-28 Univ Emory Pharmazeutische zusätze zur erhöhung der organschutzeffekte von nachkonditionierung
US7601487B2 (en) * 2005-04-12 2009-10-13 Cleo Cosmetic And Pharmaceutical Co., Llc Composition using HMW dextran and method for in vitro preservation of corneal tissues
EP1879599B1 (de) * 2005-04-20 2013-10-16 Fred Hutchinson Cancer Research Center Verfahren, zusammensetzungen und hergestellte artikel zur verbesserten überlebensfähigkeit von zellen, geweben, organen und organismen
US9078428B2 (en) 2005-06-28 2015-07-14 Transmedics, Inc. Systems, methods, compositions and solutions for perfusing an organ
EP1946763B1 (de) * 2005-11-08 2013-08-21 Ajinomoto Co., Inc. Mittel zur förderung der erholung nach einer narkose
US7854754B2 (en) 2006-02-22 2010-12-21 Zeltiq Aesthetics, Inc. Cooling device for removing heat from subcutaneous lipid-rich cells
CA2648598A1 (en) * 2006-04-03 2007-10-11 Innogene Kalbiotech Pte Ltd Lactate and calcium containing pharmaceutical composition and uses thereof
IL301141A (en) 2006-04-19 2023-05-01 Transmedics Inc Systems and methods for extracorporeal organ treatment
US8192474B2 (en) 2006-09-26 2012-06-05 Zeltiq Aesthetics, Inc. Tissue treatment methods
US9132031B2 (en) 2006-09-26 2015-09-15 Zeltiq Aesthetics, Inc. Cooling device having a plurality of controllable cooling elements to provide a predetermined cooling profile
US9457179B2 (en) 2007-03-20 2016-10-04 Transmedics, Inc. Systems for monitoring and applying electrical currents in an organ perfusion system
US20080287839A1 (en) 2007-05-18 2008-11-20 Juniper Medical, Inc. Method of enhanced removal of heat from subcutaneous lipid-rich cells and treatment apparatus having an actuator
GB0712833D0 (en) * 2007-07-03 2007-08-08 Aqix Ltd Body Fluid Expander
US8523927B2 (en) 2007-07-13 2013-09-03 Zeltiq Aesthetics, Inc. System for treating lipid-rich regions
US8285390B2 (en) 2007-08-21 2012-10-09 Zeltiq Aesthetics, Inc. Monitoring the cooling of subcutaneous lipid-rich cells, such as the cooling of adipose tissue
US20090123436A1 (en) * 2007-11-08 2009-05-14 Surmodics, Inc. Cryopreservative compositions and methods
US10750738B2 (en) 2008-01-31 2020-08-25 Transmedics, Inc. Systems and methods for ex vivo lung care
US20090263780A1 (en) * 2008-04-17 2009-10-22 Yanming Wang Organ preservation fluid
EP2346428B1 (de) 2008-09-25 2019-11-06 Zeltiq Aesthetics, Inc. Behandlungsplanungssysteme und verfahren zur körperformung
US8603073B2 (en) 2008-12-17 2013-12-10 Zeltiq Aesthetics, Inc. Systems and methods with interrupt/resume capabilities for treating subcutaneous lipid-rich cells
CN101444526B (zh) * 2008-12-30 2012-06-27 杭州民生药业有限公司 一种药物组合物
ES2916830T3 (es) 2009-04-30 2022-07-06 Zeltiq Aesthetics Inc Dispositivo para eliminar el calor de las células subcutáneas ricas en lípidos
SE534527C2 (sv) * 2009-09-24 2011-09-20 Vivoline Medical Ab Förfarande, anordning och vätska för behandling av ett hjärta efter uttagning
DE102009045589A1 (de) * 2009-10-12 2011-04-14 Universitätsklinikum Freiburg Vorrichtung zur Behandlung eines Individuums mit Herzminderleistung, Herzstillstand oder Schlaganfall
US9314368B2 (en) 2010-01-25 2016-04-19 Zeltiq Aesthetics, Inc. Home-use applicators for non-invasively removing heat from subcutaneous lipid-rich cells via phase change coolants, and associates devices, systems and methods
WO2011160012A1 (en) * 2010-06-17 2011-12-22 The Trustees Of Columbia University In The City Of New York Tissue culture media containing trimethylamine n-oxide
US8676338B2 (en) 2010-07-20 2014-03-18 Zeltiq Aesthetics, Inc. Combined modality treatment systems, methods and apparatus for body contouring applications
IT1401386B1 (it) * 2010-07-30 2013-07-18 Eurotech S P A Dispositivo di raffreddamento a liquido per schede elettroniche, in particolare per unita' di elaborazione ad elevate prestazioni
GB201020300D0 (en) 2010-11-30 2011-01-12 Vitrolife Sweden Ab Product
US10722395B2 (en) 2011-01-25 2020-07-28 Zeltiq Aesthetics, Inc. Devices, application systems and methods with localized heat flux zones for removing heat from subcutaneous lipid-rich cells
US8828710B2 (en) 2011-03-15 2014-09-09 Paragonix Technologies, Inc. System for hypothermic transport of samples
US9253976B2 (en) 2011-03-15 2016-02-09 Paragonix Technologies, Inc. Methods and devices for preserving tissues
US11178866B2 (en) 2011-03-15 2021-11-23 Paragonix Technologies, Inc. System for hypothermic transport of samples
US9867368B2 (en) 2011-03-15 2018-01-16 Paragonix Technologies, Inc. System for hypothermic transport of samples
WO2012125782A2 (en) 2011-03-15 2012-09-20 Paragonix Technologies, Inc. Apparatus for oxygenation and perfusion of tissue for organ preservation
US9426979B2 (en) 2011-03-15 2016-08-30 Paragonix Technologies, Inc. Apparatus for oxygenation and perfusion of tissue for organ preservation
AU2012242578B2 (en) 2011-04-14 2016-07-21 Transmedics, Inc. Organ care solution for ex-vivo machine perfusion of donor lungs
CN102488942B (zh) * 2011-11-22 2013-03-20 安徽双鹤药业有限责任公司 回血试验方法及其回血试验装置
US20130330706A1 (en) * 2012-06-06 2013-12-12 Evan C. Unger Fluid for Suspended Animation
US9560846B2 (en) 2012-08-10 2017-02-07 Paragonix Technologies, Inc. System for hypothermic transport of biological samples
US8785116B2 (en) 2012-08-10 2014-07-22 Paragonix Technologies, Inc. Methods for evaluating the suitability of an organ for transplant
US9844460B2 (en) 2013-03-14 2017-12-19 Zeltiq Aesthetics, Inc. Treatment systems with fluid mixing systems and fluid-cooled applicators and methods of using the same
US9545523B2 (en) 2013-03-14 2017-01-17 Zeltiq Aesthetics, Inc. Multi-modality treatment systems, methods and apparatus for altering subcutaneous lipid-rich tissue
US10575890B2 (en) 2014-01-31 2020-03-03 Zeltiq Aesthetics, Inc. Treatment systems and methods for affecting glands and other targeted structures
US10675176B1 (en) 2014-03-19 2020-06-09 Zeltiq Aesthetics, Inc. Treatment systems, devices, and methods for cooling targeted tissue
USD777338S1 (en) 2014-03-20 2017-01-24 Zeltiq Aesthetics, Inc. Cryotherapy applicator for cooling tissue
US10952891B1 (en) 2014-05-13 2021-03-23 Zeltiq Aesthetics, Inc. Treatment systems with adjustable gap applicators and methods for cooling tissue
AU2015271799B2 (en) 2014-06-02 2019-07-11 Transmedics, Inc. Ex vivo organ care system
US10935174B2 (en) 2014-08-19 2021-03-02 Zeltiq Aesthetics, Inc. Stress relief couplings for cryotherapy apparatuses
US10568759B2 (en) 2014-08-19 2020-02-25 Zeltiq Aesthetics, Inc. Treatment systems, small volume applicators, and methods for treating submental tissue
EP3229588A4 (de) 2014-12-12 2019-03-13 Freed, Darren Vorrichtung und verfahren zur organperfusion
CA2988610A1 (en) * 2015-06-10 2016-12-15 Cellphire, Inc. Composition and methods for treatment of loss of fluids leading to hypotension and/or hypovolemia
AU2016308818B2 (en) 2015-08-18 2022-04-21 Astellas Institute For Regenerative Medicine Clinical formulations
CA2997267A1 (en) 2015-09-09 2017-03-16 Transmedics, Inc. Aortic cannula for ex vivo organ care system
US10448631B2 (en) 2015-09-22 2019-10-22 East Carolina University Cryopreservation using sucralose
WO2017070112A1 (en) 2015-10-19 2017-04-27 Zeltiq Aesthetics, Inc. Vascular treatment systems, cooling devices, and methods for cooling vascular structures
CA3009414A1 (en) 2016-01-07 2017-07-13 Zeltiq Aesthetics, Inc. Temperature-dependent adhesion between applicator and skin during cooling of tissue
US10765552B2 (en) 2016-02-18 2020-09-08 Zeltiq Aesthetics, Inc. Cooling cup applicators with contoured heads and liner assemblies
CN106092848B (zh) * 2016-03-22 2018-07-06 威海威高血液净化制品有限公司 透析器超滤性能测试液
US10555831B2 (en) 2016-05-10 2020-02-11 Zeltiq Aesthetics, Inc. Hydrogel substances and methods of cryotherapy
US10682297B2 (en) 2016-05-10 2020-06-16 Zeltiq Aesthetics, Inc. Liposomes, emulsions, and methods for cryotherapy
US11382790B2 (en) 2016-05-10 2022-07-12 Zeltiq Aesthetics, Inc. Skin freezing systems for treating acne and skin conditions
US10456423B2 (en) 2016-06-13 2019-10-29 SMART SURGICAL, Inc. Compositions for biological systems and methods for preparing and using the same
US10426796B2 (en) 2016-06-13 2019-10-01 SMART SURGICAL, Inc. Compositions for biological systems and methods for preparing and using the same
ES2651717B1 (es) * 2016-07-26 2018-11-16 Lara OLLER DUQUE Solución acuosa cristaloide isotónica
EP3551198B1 (de) * 2016-12-08 2022-02-02 Cellphire Inc. Zusammensetzung und verfahren zur behandlung des verlustes von flüssigkeiten mit folgender hypotonie und/oder hypovolämie
US11076879B2 (en) 2017-04-26 2021-08-03 Zeltiq Aesthetics, Inc. Shallow surface cryotherapy applicators and related technology
WO2018226993A1 (en) 2017-06-07 2018-12-13 Paragonix Technologies, Inc. Apparatus for tissue transport and preservation
WO2020028472A1 (en) 2018-07-31 2020-02-06 Zeltiq Aesthetics, Inc. Methods, devices, and systems for improving skin characteristics
US20200208110A1 (en) 2018-11-30 2020-07-02 Cellphire, Inc. PLATELETS LOADED WITH mRNA
EP3886879A4 (de) 2018-11-30 2022-12-07 Cellphire Inc. Thrombozyten als freisetzungsmittel
WO2020227149A1 (en) 2019-05-03 2020-11-12 Cellphire, Inc. Materials and methods for producing blood products
AU2020289541A1 (en) 2019-06-03 2021-12-16 Cooler Heads Care, Inc Cooling cap assembly and cooling unit
CN114450066A (zh) 2019-08-16 2022-05-06 塞尔菲乐有限公司 作为抗血小板剂逆转剂的血栓小体
US11632951B2 (en) 2020-01-31 2023-04-25 Paragonix Technologies, Inc. Apparatus for tissue transport and preservation
CA3170201A1 (en) 2020-02-04 2021-08-12 Cellphire, Inc. Methods of treating congenital hemophilia with anti-fibrinolytic loaded platelets
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
IT202000027050A1 (it) * 2020-11-12 2022-05-12 S A L F S P A Laboratorio Farm Soluzione colloidale per la perfusione e la conservazione ex-vivo dei polmoni

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US34077A (en) * 1862-01-07 Improvement in weighing-registers
US3356570A (en) * 1964-11-27 1967-12-05 Trustees Of Barnes Hospital Composition for treating shock
US3758382A (en) * 1968-07-26 1973-09-11 Us Navy Ve agent process of freezing blood using a hydroxyalkyl starch as cryoprotecti
ZA702706B (en) * 1969-04-28 1971-12-29 Knox Gelatine Inc Blood plasma substitute
US3897550A (en) * 1971-06-01 1975-07-29 Cybersol Method for administering water soluble drugs, nutrients and other solutes to a mammal
US3937821A (en) * 1971-08-21 1976-02-10 Kyorin Seiyaku Kabushiki Kaisha Plasma substitute including artificial starch and method for the preparation thereof
US3949098A (en) * 1974-06-05 1976-04-06 Nabisco, Inc. Nutritious orange drink concentrate, process and drink resultant therefrom
US4061736A (en) * 1975-02-02 1977-12-06 Alza Corporation Pharmaceutically acceptable intramolecularly cross-linked, stromal-free hemoglobin
US4001401A (en) * 1975-02-02 1977-01-04 Alza Corporation Blood substitute and blood plasma expander comprising polyhemoglobin
DE2801123C2 (de) * 1977-01-26 1986-01-02 Armour Pharma GmbH & Co KG, 3440 Eschwege Verfahren zur Herstellung eines intravenös applizierbaren Serumeiweiß-Präparates
US4609372A (en) * 1983-10-13 1986-09-02 Miles Laboratories, Inc. Heat sterilizable storage solution for red blood cells
AU583272B2 (en) * 1984-04-27 1989-04-27 Synthetic Blood Corporation Coacervate system synthetic whole blood substitute
AU4634685A (en) * 1984-06-22 1986-01-24 R.L. Veech Electrolyte solutions and in vivo use thereof
US5084377A (en) * 1984-09-19 1992-01-28 Larry Rowan Cryogenic suspension method
US4879283A (en) * 1985-10-03 1989-11-07 Wisconsin Alumni Research Foundation Solution for the preservation of organs
US4908350A (en) * 1985-10-31 1990-03-13 The Regents Of The University Of California Hyperosmotic/hyperoncotic solutions for resuscitation of hypodynamic shock
US4769318A (en) * 1986-06-03 1988-09-06 Ube Industries, Ltd. Additive solution for blood preservation and activation
US5210083A (en) * 1986-07-17 1993-05-11 Ed. Geistlich Sohne A.G. Fur Chemische Industrie Pharmaceutical compositions
JPS6360931A (ja) * 1986-08-29 1988-03-17 Noboru Sato 血液または血液製剤保存液およびこれを用いた血液または血液製剤の保存方法
US4927806A (en) * 1987-04-23 1990-05-22 The Regents Of The University Of California Saturated salt/concentrated dextran formulation to treat hemorrhage
AU2900889A (en) * 1987-12-24 1989-07-19 Thomas Julius Borody Orthostatic lavage solutions
US4923442A (en) * 1988-05-02 1990-05-08 Cryomedical Sciences Inc. Blood substitute
US5130230A (en) * 1988-05-02 1992-07-14 Cryomedical Sciences, Inc. Blood substitute
USRE34077E (en) * 1988-05-02 1992-09-22 Cryomedical Sciences, Inc. Blood substitute
JPH03220201A (ja) * 1988-11-18 1991-09-27 Eisai Co Ltd プロスタグランジン類と多糖類の結合体
US5252213A (en) * 1989-06-20 1993-10-12 University Of Washington Dry dialysate composition
US5082831A (en) * 1989-12-05 1992-01-21 Cryovita Laboratories, Inc. Total body washout solution and method of use
US5171526A (en) * 1990-01-05 1992-12-15 Allergan, Inc. Ophthalmic compositions and methods for preserving and using same
EP0523037A4 (en) * 1990-03-30 1993-07-28 Biomedical Frontiers, Inc. Fluid resuscitation
US5416078A (en) * 1990-03-30 1995-05-16 Biomedical Frontiers, Inc. Fluid resuscitation
US5248766A (en) * 1990-08-17 1993-09-28 Baxter International Inc. Oxirane-modified hemoglobin based composition
GB9021325D0 (en) * 1990-10-01 1990-11-14 Geistlich Soehne Ag Chemical composition
WO1992008349A1 (en) * 1990-11-07 1992-05-29 Baxter International Inc. Blood platelet storage medium
CA2066374C (en) * 1991-04-19 2002-01-29 Paul E. Segall Solution for perfusing primates
EP0663821A4 (de) * 1991-08-08 1997-09-17 Leigh D Segel Blutersatzmittel mit fluorkohlenstoffen.
US5407428A (en) * 1993-06-04 1995-04-18 Biotime, Inc. Solutions for use as plasma expanders and substitutes
JP3715312B2 (ja) * 1993-06-04 2005-11-09 バイオタイム インク 血漿様溶液

Also Published As

Publication number Publication date
HK1010698A1 (en) 1999-06-25
ES2157260T3 (es) 2001-08-16
US6387612B1 (en) 2002-05-14
JPH08511265A (ja) 1996-11-26
US20020009783A1 (en) 2002-01-24
CA2164321A1 (en) 1994-12-22
CA2164321C (en) 2002-08-20
US6110504A (en) 2000-08-29
JP3715312B2 (ja) 2005-11-09
EP0701455A4 (de) 1998-01-07
WO1994028950A1 (en) 1994-12-22
US6406839B1 (en) 2002-06-18
CN1102851C (zh) 2003-03-12
US5733894A (en) 1998-03-31
US6444418B2 (en) 2002-09-03
ATE199626T1 (de) 2001-03-15
EP0701455A1 (de) 1996-03-20
US5698536A (en) 1997-12-16
US5613944A (en) 1997-03-25
US5968726A (en) 1999-10-19
US6410218B2 (en) 2002-06-25
AU681675B2 (en) 1997-09-04
BR9406742A (pt) 1996-03-12
US5747071A (en) 1998-05-05
US20020025562A1 (en) 2002-02-28
EP0701455B1 (de) 2001-03-14
GR3036013T3 (en) 2001-09-28
PT701455E (pt) 2001-09-27
US5723281A (en) 1998-03-03
US5702880A (en) 1997-12-30
US6080538A (en) 2000-06-27
DK0701455T3 (da) 2001-06-18
DE69426879T2 (de) 2001-10-18
KR100267604B1 (ko) 2000-11-01
CN1127476A (zh) 1996-07-24
RU2142282C1 (ru) 1999-12-10
US5571801A (en) 1996-11-05
US20020012957A1 (en) 2002-01-31
AU7052594A (en) 1995-01-03

Similar Documents

Publication Publication Date Title
ATE199626T1 (de) Plasma-artige lösung
US5552267A (en) Solution for prolonged organ preservation
CA2066374A1 (en) Solution for perfusing primates
KR890009409A (ko) 기관 보존 및 저장에 적당한 조성물 및 기관 보조 방법
ATE235813T1 (de) Verfahren zur vorbereitung von organen auf die kryokonservierung
DK0418339T3 (da) Præparat og fremgangsmåde til forebyggelse af sammenvoksninger mellem kropsvæv
PT852491E (pt) Utilizacao de heparinases para diminuir respostas inflamatorias
KR100855354B1 (ko) 관류세척 보존 용액
US6589223B1 (en) Method and compositions for use in perfusion applications
Hällgren et al. Accumulation of hyaluronan (hyaluronic acid) in myocardial interstitial tissue parallels development of transplantation edema in heart allografts in rats.
IE891118L (en) Topical preparation for treating otopathy
DE69729958D1 (de) Verbindungen mit antiviraler aktivität
Ladaga et al. Preservation of canine kidneys by hypothermia and hyperbaric oxygen: long-term survival of autografts following 24-hour storage
Klotz The adherence of Candida yeasts to human and bovine vascular endothelium and subendothelial extracellular matrix
EP0551359A1 (de) Chemische zusammensetzungen.
Chang-Chun et al. Effect of a cyclic adenosine monophosphate phosphodiesterase inhibitor, DN-9693, on myocardial reperfusion injury
US5434187A (en) Eye drops
Barner Allogenic vein as a conduit for coronary artery bypass
Fujinami et al. Fibrinolytic activity of the endothelium
Ellis Histochemical demonstration of endogenous dehydrogenase systems by supravital perfusion
BG104385A (en) Physiologically acceptable aqueous solutions and methods for their application
KR20010104329A (ko) 기관보호 용액
WO2000042986A8 (de) Künstliche tränenflüssigkeit in gelform
Sułowicz et al. Peroxidase activity in peritoneal macrophages of patients with terminal renal failure treated by intermittent peritoneal dialysis
JPH0977680A (ja) ハプトグロビン含有液状製剤

Legal Events

Date Code Title Description
8364 No opposition during term of opposition